AIP
SER icon

Ameritas Investment Partners’s Serina Therapeutics SER Stock Holding History

Ameritas Investment Partners’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17
Closed -$1K – 3151
2020
Q1 		$1K Hold
17
– – ﹤0.01% 3010
2019
Q4 		$1K Hold
17
– – ﹤0.01% 3001
2019
Q3 		$1K Hold
17
– – ﹤0.01% 3052
2019
Q2 		$2K Hold
17
– – ﹤0.01% 3027
2019
Q1 		$2K Hold
17
– – ﹤0.01% 2955
2018
Q4 		$2K Buy
+17
New +$2.16K ﹤0.01% 2963

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Ameritas Investment Partners's SER Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Serina Therapeutics (SER) in Q2 2020, closing a stake of 17 shares — an estimated $1K sold.

Ameritas Investment Partners first reported a position in SER in Q4 2018 and held it in 6 quarters. The position peaked at $2K in Q2 2019. 48 funds tracked by Wall St. Rank hold SER as of Q2 2020.

  • Ameritas Investment Partners reported no remaining Serina Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 17 Serina Therapeutics shares in Q2 2020, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Serina Therapeutics in Q4 2018 and held it in 6 quarters.
  • Ameritas Investment Partners's Serina Therapeutics position peaked at $2K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.